french and danish companies invest in biotechnology

1
MARKETS AND BUSINESS US demand for chemical catalysts forecast to expand 3.3%/y to 2009 Chemical catalyst demand in the USA is projected to grow 3.3%/y to 2009, according to a recent study from industrial market research firm The Freedonia Group Inc. The report stated that continued robust demand for olefin-based materials and ethylene glycol-based polyesters will result in near average growth for the petrochemicals industry. However, demand for inorganic chemical catalysts will drop due to the effect of high prices of natural gas on ammonia, and accordingly, nitric acid production. Alcohols will experience the most rapid growth as the ethanol industry continues to grow rapidly to conform to the standard under the Energy Policy Act of 2005. Hydrocarbon Processing, Dec 2005, 84 (12), 7 Catalysts are driving big deals BASF estimates that the automotive catalyst market is worth $2.5 bn. It has launched a $4.9 bn cash bid for Engelhard Corp. This would allow BASF to expand its automotive catalysts business as will as strengthen its position for speciality pigments. Engelhard produces catalysts for automotive, pollution control, chemical, polyolefin, and petroleum applications. It had sales of $3.3 bn for Jan-Sep 2005. Its 2004 sales of $4.2 bn were split: Environmental Technologies division 22% (automotive and non-automotive catalysts), Process Technologies division 15% and Appearance and Performance Technologies division 17% (mainly pigments) and Materials Services (base and precious metal services for Engelhard’s catalyst activities and external clients) 46%. Catalyst sales are being boosted by increased environmental legislation in N America, the EU, and Japan as well as market expansion in India, Russia, China, and S America. Engelhard has around 30% of the fluid-cracking catalyst market. Chemical Market Reporter, 16 Jan 2006 (Website: http://www.chemicalmarketreporter.com) French and Danish companies invest in biotechnology The French company Spef Venture and the Danish companies Vecata and Incuba Venture are to contribute to the 6 M capital increase that the Danish biotechnology company Fluxome Sciences has agreed. The investment is to speed up the R&D of Fluxome Sciences. The research is into biological routes to new chemical compounds, and into cheaper and less polluting routes to traditional chemical compounds. The microorganisms used include moulds, yeasts, and bacteria. Enzymes too are used. The company aims to improve current bioprocesses. According to the US government, this market should rise from the present $50 bn/y to $500 bn in 2020. The processes being developed are for use in the pharmaceutical, nutraceutical, food, and drinks industries. Chimie Pharma Hebdo, 16 Jan 2006, (325), 13 (in French) Novozymes and Danisco interested in US energy policy switch On 1 Feb 2006 the share price of Novozymes rose by 6.2% to DKR 362.5 and that of Danisco by 1.4% to DKR 475.0 against the background of the State of the Union address by President Bush. In this it was stated that research into the creation of biomass for ethanol production will be strengthened and that by 2025 75% of oil imports from the Middle East would be replaced by alternatives, including ethanol. This was interesting news for Novozymes and Danisco both of which develop and manufacture enzymes for the production of fuel ethanol. Dagbladet Borsen, 1 Feb 2006 (Website: http://www.borsen.dk) (in Danish) Synthetic zeolites: presence growing in environment and new energy fields The unique adsorptive, catalytic, and ion-exchange properties of zeolites are leading to new applications including resin additives and in environmental conservation situations where they can be used to remove hazardous substances and offensive odours. Additional applications include production of industrial gases by separation of oxygen and nitrogen in air. The use of zeolites as molecular sieves is being promoted by Union Showa KK, a major producer. Other major producers include Tosoh Corp, Mizusawa Industrial Chemicals, Nippon Chemical Industrial, and Zeochem (Switzerland). Pacific Chemical Marketing Co is the Japanese agency for Zeochem. The Swiss company is promoting the use of zeolites for removal of odour and foreign materials from gasoline, particularly in markets such as India. The wide range of applications for zeolites is outlined. Japan Chemical Week, 22/29 Dec 2005, 46 (2348), 6-7 UK starts work on National Biotech Centre Thermal Transfer has been awarded a procurement, construction, and commissioning contract by the Centre for Process Innovation for a pilot-scale biocatalyst facility at Wilton, UK. It will be known as the National Industrial Biotechnology Facility, and will be completed before the end of 2006. It will cost around £6.5 M, with funding provided by regional government agencies in northern England. The unit should be self-financing within 2 years. Chemical Week, 25 Jan 2006, 168 (3), 22 COMPANY NEWS Albemarle surges on catalyst play Albemarle’s share price increased to $40.97 /share, up $2.62 following an announcement that BASF had bid for Engelhard. Chemical Market Reporter, 9 Jan 2006 (Website: http://www.chemicalmarketreporter.com) BASF makes unsuccessful bid for Engelhard BASF has made a hostile bid to take over Engelhard for $4.9 bn in cash, or $37/share. The move would make BASF a world leader in catalysts. Engelhard advised shareholders to take no action for the moment. Engelhard then formally rejected BASF’s takeover offer, saying it is “opportunistic and undervalues Engelhard.” Engelhard’s board has 2 MARCH 2006 FOCUS ON CATALYSTS

Post on 05-Jul-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: French and Danish companies invest in biotechnology

MARKETS ANDBUSINESS

US demand for chemical catalystsforecast to expand 3.3%/y to 2009

Chemical catalyst demand in the USAis projected to grow 3.3%/y to 2009,according to a recent study fromindustrial market research firm TheFreedonia Group Inc. The reportstated that continued robust demandfor olefin-based materials andethylene glycol-based polyesters willresult in near average growth for thepetrochemicals industry. However,demand for inorganic chemicalcatalysts will drop due to the effect ofhigh prices of natural gas onammonia, and accordingly, nitric acidproduction. Alcohols will experiencethe most rapid growth as the ethanolindustry continues to grow rapidly toconform to the standard under theEnergy Policy Act of 2005.

Hydrocarbon Processing, Dec 2005, 84 (12), 7

Catalysts are driving big deals

BASF estimates that the automotivecatalyst market is worth $2.5 bn. Ithas launched a $4.9 bn cash bid forEngelhard Corp. This would allowBASF to expand its automotivecatalysts business as will asstrengthen its position for specialitypigments. Engelhard producescatalysts for automotive, pollutioncontrol, chemical, polyolefin, andpetroleum applications. It had sales of$3.3 bn for Jan-Sep 2005. Its 2004sales of $4.2 bn were split:Environmental Technologies division22% (automotive and non-automotivecatalysts), Process Technologiesdivision 15% and Appearance andPerformance Technologies division17% (mainly pigments) and MaterialsServices (base and precious metalservices for Engelhard’s catalystactivities and external clients) 46%.Catalyst sales are being boosted byincreased environmental legislation inN America, the EU, and Japan as wellas market expansion in India, Russia,China, and S America. Engelhard hasaround 30% of the fluid-crackingcatalyst market.

Chemical Market Reporter, 16 Jan 2006 (Website:http://www.chemicalmarketreporter.com)

French and Danish companies invest inbiotechnology

The French company Spef Venture andthe Danish companies Vecata andIncuba Venture are to contribute to the€6 M capital increase that the Danishbiotechnology company FluxomeSciences has agreed. The investmentis to speed up the R&D of FluxomeSciences. The research is intobiological routes to new chemicalcompounds, and into cheaper and lesspolluting routes to traditional chemicalcompounds. The microorganisms usedinclude moulds, yeasts, and bacteria.Enzymes too are used. The companyaims to improve current bioprocesses.According to the US government, thismarket should rise from the present$50 bn/y to $500 bn in 2020. Theprocesses being developed are for usein the pharmaceutical, nutraceutical,food, and drinks industries.

Chimie Pharma Hebdo, 16 Jan 2006, (325), 13 (inFrench)

Novozymes and Danisco interested inUS energy policy switch

On 1 Feb 2006 the share price ofNovozymes rose by 6.2% to DKR362.5 and that of Danisco by 1.4% toDKR 475.0 against the background ofthe State of the Union address byPresident Bush. In this it was statedthat research into the creation ofbiomass for ethanol production will bestrengthened and that by 2025 75% ofoil imports from the Middle East wouldbe replaced by alternatives, includingethanol. This was interesting news forNovozymes and Danisco both of whichdevelop and manufacture enzymes forthe production of fuel ethanol.

Dagbladet Borsen, 1 Feb 2006 (Website:http://www.borsen.dk) (in Danish)

Synthetic zeolites: presence growingin environment and new energy fields

The unique adsorptive, catalytic, andion-exchange properties of zeolitesare leading to new applicationsincluding resin additives and inenvironmental conservation situationswhere they can be used to removehazardous substances and offensiveodours. Additional applicationsinclude production of industrial gasesby separation of oxygen and nitrogenin air. The use of zeolites as

molecular sieves is being promotedby Union Showa KK, a majorproducer. Other major producersinclude Tosoh Corp, MizusawaIndustrial Chemicals, NipponChemical Industrial, and Zeochem(Switzerland). Pacific ChemicalMarketing Co is the Japanese agencyfor Zeochem. The Swiss company ispromoting the use of zeolites forremoval of odour and foreign materialsfrom gasoline, particularly in marketssuch as India. The wide range ofapplications for zeolites is outlined.

Japan Chemical Week, 22/29 Dec 2005, 46 (2348), 6-7

UK starts work on National BiotechCentre

Thermal Transfer has been awarded aprocurement, construction, andcommissioning contract by the Centrefor Process Innovation for a pilot-scalebiocatalyst facility at Wilton, UK. It willbe known as the National IndustrialBiotechnology Facility, and will becompleted before the end of 2006. Itwill cost around £6.5 M, with fundingprovided by regional governmentagencies in northern England. The unitshould be self-financing within 2 years.

Chemical Week, 25 Jan 2006, 168 (3), 22

COMPANYNEWS

Albemarle surges on catalyst play

Albemarle’s share price increased to$40.97 /share, up $2.62 following anannouncement that BASF had bid forEngelhard.

Chemical Market Reporter, 9 Jan 2006 (Website:http://www.chemicalmarketreporter.com)

BASF makes unsuccessful bid forEngelhard

BASF has made a hostile bid to takeover Engelhard for $4.9 bn in cash, or$37/share. The move would makeBASF a world leader in catalysts.Engelhard advised shareholders totake no action for the moment.Engelhard then formally rejectedBASF’s takeover offer, saying it is“opportunistic and undervaluesEngelhard.” Engelhard’s board has

2 MARCH 2006

F O C U S O N C A T A L Y S T S